APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Supply Chain and Logistics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cell and Gene Therapy Supply Chain and Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

11 April 2026194 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Supply Chain and Logistics Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Supply Chain and Logistics Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Supply Chain and Logistics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Supply Chain and Logistics Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Supply Chain and Logistics Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Supply Chain and Logistics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cell and Gene Therapy Supply Chain and Logistics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cell and Gene Therapy Supply Chain and Logistics include Be The Match BioTherapies, Biocair, Marken, World Courier, MAK-SYSTEM, Cryoport, Brooks Life Sciences, Hypertrust Patient Data Care and Haemonetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cell and Gene Therapy Supply Chain and Logistics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cell and Gene Therapy Supply Chain and Logistics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cell and Gene Therapy Supply Chain and Logistics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell and Gene Therapy Supply Chain and Logistics market size, projected growth trends, production technologies, key applications, and end-use industries.

Cell and Gene Therapy Supply Chain and Logistics Segment by Company

Be The Match BioTherapies

Biocair

Marken

World Courier

MAK-SYSTEM

Cryoport

Brooks Life Sciences

Hypertrust Patient Data Care

Haemonetics

MasterControl

TraceLink

TrakCel

Stafa Cellular Therapy

McKesson

BioLife Solutions

Patheon

SF Express

Cell and Gene Therapy Supply Chain and Logistics Segment by Type

Ordering and Scheduling Services

Sample Collection Services

Logistics Services

Post Treatment Follow-Up Services

Cell and Gene Therapy Supply Chain and Logistics Segment by Application

Biobank

Cell Therapy Lab

Hospital

Research Institute

Cell and Gene Therapy Supply Chain and Logistics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Supply Chain and Logistics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Supply Chain and Logistics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Supply Chain and Logistics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell and Gene Therapy Supply Chain and Logistics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell and Gene Therapy Supply Chain and Logistics industry.

Chapter 3: Detailed analysis of Cell and Gene Therapy Supply Chain and Logistics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Supply Chain and Logisticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Ordering and Scheduling Services Table 3. Key Players of Sample Collection Services Table 4. Key Players of Logistics Services Table 3. Key Players of Post Treatment Follow-Up Services Table 4. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Biobank Table 6. Key Players of Cell Therapy Lab Table 7. Key Players of Hospital Table 8. Key Players of Research Institute Table 9. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2021-2026) Table 12. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region (2027-2032) Table 14. Cell and Gene Therapy Supply Chain and Logistics Industry Trends Table 15. Cell and Gene Therapy Supply Chain and Logistics Industry Drivers Table 16. Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges Table 17. Cell and Gene Therapy Supply Chain and Logistics Industry Restraints Table 18. Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Company (2021-2026) Table 20. Global Cell and Gene Therapy Supply Chain and Logistics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell and Gene Therapy Supply Chain and Logistics Key Company Head Office and Area Served Table 22. Global Cell and Gene Therapy Supply Chain and Logistics Company, Product Type & Application Table 23. Global Cell and Gene Therapy Supply Chain and Logistics Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell and Gene Therapy Supply Chain and Logistics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2021-2026) Table 30. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2027-2032) Table 31. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2021-2026) Table 35. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2027-2032) Table 36. Be The Match BioTherapies Company Information Table 37. Be The Match BioTherapies Business Overview Table 38. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 40. Be The Match BioTherapies Recent Development Table 41. Biocair Company Information Table 42. Biocair Business Overview Table 43. Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 45. Biocair Recent Development Table 46. Marken Company Information Table 47. Marken Business Overview Table 48. Marken Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 50. Marken Recent Development Table 51. World Courier Company Information Table 52. World Courier Business Overview Table 53. World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 55. World Courier Recent Development Table 56. MAK-SYSTEM Company Information Table 57. MAK-SYSTEM Business Overview Table 58. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 60. MAK-SYSTEM Recent Development Table 61. Cryoport Company Information Table 62. Cryoport Business Overview Table 63. Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 65. Cryoport Recent Development Table 66. Brooks Life Sciences Company Information Table 67. Brooks Life Sciences Business Overview Table 68. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 70. Brooks Life Sciences Recent Development Table 71. Hypertrust Patient Data Care Company Information Table 72. Hypertrust Patient Data Care Business Overview Table 73. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 75. Hypertrust Patient Data Care Recent Development Table 76. Haemonetics Company Information Table 77. Haemonetics Business Overview Table 78. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 80. Haemonetics Recent Development Table 81. MasterControl Company Information Table 82. MasterControl Business Overview Table 83. MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 85. MasterControl Recent Development Table 86. TraceLink Company Information Table 87. TraceLink Business Overview Table 88. TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 90. TraceLink Recent Development Table 91. TrakCel Company Information Table 92. TrakCel Business Overview Table 93. TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 95. TrakCel Recent Development Table 96. Stafa Cellular Therapy Company Information Table 97. Stafa Cellular Therapy Business Overview Table 98. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 100. Stafa Cellular Therapy Recent Development Table 101. McKesson Company Information Table 102. McKesson Business Overview Table 103. McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 105. McKesson Recent Development Table 106. BioLife Solutions Company Information Table 107. BioLife Solutions Business Overview Table 108. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 110. BioLife Solutions Recent Development Table 111. Patheon Company Information Table 112. Patheon Business Overview Table 113. Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 115. Patheon Recent Development Table 116. SF Express Company Information Table 117. SF Express Business Overview Table 118. SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio Table 120. SF Express Recent Development Table 121. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 122. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (US$ Million) Table 123. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 124. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (US$ Million) Table 125. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) Table 127. North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032) Table 128. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 129. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (US$ Million) Table 130. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 131. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (US$ Million) Table 132. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) Table 134. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032) Table 135. China Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 136. China Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (US$ Million) Table 137. China Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 138. China Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (US$ Million) Table 139. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 140. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (US$ Million) Table 141. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 142. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) Table 145. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032) Table 146. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026) & (US$ Million) Table 149. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032) & (US$ Million) Table 150. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026) Table 152. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Supply Chain and Logistics Product Image Figure 2. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Type: 2025 VS 2032 Figure 4. Ordering and Scheduling Services Image Figure 5. Sample Collection Services Image Figure 6. Logistics Services Image Figure 7. Post Treatment Follow-Up Services Image Figure 8. Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Application: 2025 VS 2032 Figure 10. Biobank Image Figure 11. Cell Therapy Lab Image Figure 12. Hospital Image Figure 13. Research Institute Image Figure 14. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 16. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Cell and Gene Therapy Supply Chain and Logistics Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Cell and Gene Therapy Supply Chain and Logistics Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Type (2021-2032) Figure 23. Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cell and Gene Therapy Supply Chain and Logistics Revenue Market Share by Application (2021-2032) Figure 25. North America Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 26. North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032) Figure 27. North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032) Figure 28. North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 29. United States Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 30. Canada Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 32. Europe Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 33. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032) Figure 34. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032) Figure 35. Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 36. Germany Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 37. France Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 39. Italy Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 40. Russia Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 42. China Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 43. China Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032) Figure 44. China Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032) Figure 45. Asia Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 46. Asia Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032) Figure 47. Asia Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032) Figure 48. Asia Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 49. Japan Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 53. India Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 54. Australia Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032) Figure 59. Brazil Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 64. UAE Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 66. Chile Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Ordering and Scheduling Services
  • Sample Collection Services
  • Logistics Services
  • Post Treatment Follow-Up Services
Applications
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
Companies covered
  • Be The Match BioTherapies
  • Biocair
  • Marken
  • World Courier
  • MAK-SYSTEM
  • Cryoport
  • Brooks Life Sciences
  • Hypertrust Patient Data Care
  • Haemonetics
  • MasterControl
  • TraceLink
  • TrakCel
  • Stafa Cellular Therapy
  • McKesson
  • BioLife Solutions
  • Patheon
  • SF Express

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Ordering and Scheduling Services
  5. 1.2.3 Sample Collection Services
  6. 1.2.4 Logistics Services
  7. 1.2.5 Post Treatment Follow-Up Services
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Biobank
  11. 1.3.3 Cell Therapy Lab
  12. 1.3.4 Hospital
  13. 1.3.5 Research Institute
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Cell and Gene Therapy Supply Chain and Logistics Growth Trends by Region
  16. 1.5.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2021-2026)
  18. 1.5.3 Cell and Gene Therapy Supply Chain and Logistics Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Cell and Gene Therapy Supply Chain and Logistics Market Dynamics
  1. 2.1 Cell and Gene Therapy Supply Chain and Logistics Industry Trends
  2. 2.2 Cell and Gene Therapy Supply Chain and Logistics Industry Drivers
  3. 2.3 Cell and Gene Therapy Supply Chain and Logistics Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Supply Chain and Logistics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cell and Gene Therapy Supply Chain and Logistics Revenue by Company (2021-2026)
  2. 3.2 Global Cell and Gene Therapy Supply Chain and Logistics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cell and Gene Therapy Supply Chain and Logistics Key Company Head office and Area Served
  4. 3.4 Global Cell and Gene Therapy Supply Chain and Logistics Company, Product Type & Application
  5. 3.5 Global Cell and Gene Therapy Supply Chain and Logistics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cell and Gene Therapy Supply Chain and Logistics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cell and Gene Therapy Supply Chain and Logistics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cell and Gene Therapy Supply Chain and Logistics Tier 1, Tier 2, and Tier 3
4 Cell and Gene Therapy Supply Chain and Logistics Market by Type
  1. 4.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2032)
  3. 4.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Type (2021-2032)
5 Cell and Gene Therapy Supply Chain and Logistics Market by Application
  1. 5.1 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Supply Chain and Logistics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Be The Match BioTherapies
  2. 6.1.1 Be The Match BioTherapies Company Information
  3. 6.1.2 Be The Match BioTherapies Business Overview
  4. 6.1.3 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Be The Match BioTherapies Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  6. 6.1.5 Be The Match BioTherapies Recent Developments
  7. 6.2 Biocair
  8. 6.2.1 Biocair Company Information
  9. 6.2.2 Biocair Business Overview
  10. 6.2.3 Biocair Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Biocair Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  12. 6.2.5 Biocair Recent Developments
  13. 6.3 Marken
  14. 6.3.1 Marken Company Information
  15. 6.3.2 Marken Business Overview
  16. 6.3.3 Marken Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Marken Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  18. 6.3.5 Marken Recent Developments
  19. 6.4 World Courier
  20. 6.4.1 World Courier Company Information
  21. 6.4.2 World Courier Business Overview
  22. 6.4.3 World Courier Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 World Courier Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  24. 6.4.5 World Courier Recent Developments
  25. 6.5 MAK-SYSTEM
  26. 6.5.1 MAK-SYSTEM Company Information
  27. 6.5.2 MAK-SYSTEM Business Overview
  28. 6.5.3 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 MAK-SYSTEM Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  30. 6.5.5 MAK-SYSTEM Recent Developments
  31. 6.6 Cryoport
  32. 6.6.1 Cryoport Company Information
  33. 6.6.2 Cryoport Business Overview
  34. 6.6.3 Cryoport Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cryoport Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  36. 6.6.5 Cryoport Recent Developments
  37. 6.7 Brooks Life Sciences
  38. 6.7.1 Brooks Life Sciences Company Information
  39. 6.7.2 Brooks Life Sciences Business Overview
  40. 6.7.3 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Brooks Life Sciences Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  42. 6.7.5 Brooks Life Sciences Recent Developments
  43. 6.8 Hypertrust Patient Data Care
  44. 6.8.1 Hypertrust Patient Data Care Company Information
  45. 6.8.2 Hypertrust Patient Data Care Business Overview
  46. 6.8.3 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Hypertrust Patient Data Care Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  48. 6.8.5 Hypertrust Patient Data Care Recent Developments
  49. 6.9 Haemonetics
  50. 6.9.1 Haemonetics Company Information
  51. 6.9.2 Haemonetics Business Overview
  52. 6.9.3 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Haemonetics Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  54. 6.9.5 Haemonetics Recent Developments
  55. 6.10 MasterControl
  56. 6.10.1 MasterControl Company Information
  57. 6.10.2 MasterControl Business Overview
  58. 6.10.3 MasterControl Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 MasterControl Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  60. 6.10.5 MasterControl Recent Developments
  61. 6.11 TraceLink
  62. 6.11.1 TraceLink Company Information
  63. 6.11.2 TraceLink Business Overview
  64. 6.11.3 TraceLink Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 TraceLink Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  66. 6.11.5 TraceLink Recent Developments
  67. 6.12 TrakCel
  68. 6.12.1 TrakCel Company Information
  69. 6.12.2 TrakCel Business Overview
  70. 6.12.3 TrakCel Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 TrakCel Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  72. 6.12.5 TrakCel Recent Developments
  73. 6.13 Stafa Cellular Therapy
  74. 6.13.1 Stafa Cellular Therapy Company Information
  75. 6.13.2 Stafa Cellular Therapy Business Overview
  76. 6.13.3 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Stafa Cellular Therapy Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  78. 6.13.5 Stafa Cellular Therapy Recent Developments
  79. 6.14 McKesson
  80. 6.14.1 McKesson Company Information
  81. 6.14.2 McKesson Business Overview
  82. 6.14.3 McKesson Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 McKesson Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  84. 6.14.5 McKesson Recent Developments
  85. 6.15 BioLife Solutions
  86. 6.15.1 BioLife Solutions Company Information
  87. 6.15.2 BioLife Solutions Business Overview
  88. 6.15.3 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 BioLife Solutions Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  90. 6.15.5 BioLife Solutions Recent Developments
  91. 6.16 Patheon
  92. 6.16.1 Patheon Company Information
  93. 6.16.2 Patheon Business Overview
  94. 6.16.3 Patheon Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Patheon Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  96. 6.16.5 Patheon Recent Developments
  97. 6.17 SF Express
  98. 6.17.1 SF Express Company Information
  99. 6.17.2 SF Express Business Overview
  100. 6.17.3 SF Express Cell and Gene Therapy Supply Chain and Logistics Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 SF Express Cell and Gene Therapy Supply Chain and Logistics Product Portfolio
  102. 6.17.5 SF Express Recent Developments
7 North America
  1. 7.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  2. 7.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  3. 7.2.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
  4. 7.2.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
  5. 7.2.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032)
  6. 7.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  7. 7.3.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
  8. 7.3.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
  9. 7.3.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032)
  10. 7.4 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  11. 7.4.1 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  13. 7.4.3 North America Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032)
  14. 7.4.4 North America Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  2. 8.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  3. 8.2.1 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032)
  6. 8.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  7. 8.3.1 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032)
  10. 8.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  11. 8.4.1 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  2. 9.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  3. 9.2.1 China Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
  4. 9.2.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
  5. 9.2.3 China Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032)
  6. 9.3 China Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  7. 9.3.1 China Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
  8. 9.3.2 China Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
  9. 9.3.3 China Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  2. 10.2 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  3. 10.2.1 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032)
  6. 10.3 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  7. 10.3.1 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032)
  10. 10.4 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  11. 10.4.1 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cell and Gene Therapy Supply Chain and Logistics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst